Source: Virtual Congress 2021 – Highlights in COVID-19 diagnosis and treatment



Rating:

Share or cite this content

Citations should be made in the following way:
J. Lascarrou (Nantes, France), G. Colin (La Roche-sur-Yon, France), A. Le Thuaut (Nantes, France), N. Serck (Ottignies, Belgium), M. Ohana (Strasbourg, France), B. Sauneuf (Cherbourg-en-Cotentin, France), G. Geri (Boulogne Billancourt, France), J. Mesland (Jolimont, Belgium), G. Ribeyre (Avignon, France), C. Hussenet (Nantes, France), A. Boureau (Nantes, France), T. Gille (Bobigny, France). Predictors of negative first SARS-CoV-2 PCR despite final diagnosis of COVID-19 and association with outcome. 2662

Member's Comments

No comment yet.

Related content which might interest you: Descriptive study of patients admitted to hospital for suspected COVID19 with initial negative PCR: clinical characteristics, methods of confirmation, and most common alternative diagnoses. Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 Relationship between active TB case finding and treatment outcomes Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021 Prognostic usefulness of severity scales for the initial assessment of elderly people with a diagnosis of pneumonia due to COVID-19. Design of a multivariate predictive model of mortality. Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 Does gender has any effect on tuberculosis diagnosis and treatment outcomes? Source: Eur Respir J 2003; 22: Suppl. 45, 520s Year: 2003 The outcome of tuberculosis cases who still smear positive at the end of extended initial phase Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis Year: 2008 Primary ciliary dyskinesia: predictors of early diagnosis and impact of diagnosis on clinical course Source: Eur Respir J 2004; 24: Suppl. 48, 624s Year: 2004 Is there any connection between depression and smear positive TB patient's outcome? Source: Eur Respir J 2003; 22: Suppl. 45, 155s Year: 2003 IPF cluster analysis highlights diagnostic delay and cardiovascular comorbidities association with outcome Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Impact of social of social risk factor on treatment outcome in patients with culture positive pulmonary tuberculosis (CPPTB) Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012 Role of PCR and ELISA in the diagnosis of tuberculosis in children from risk groups Source: Eur Respir J 2001; 18: Suppl. 33, 498s Year: 2001 An acute onset with unexpected final diagnosis Source: International Congress 2018 – Clinical Grand Round Year: 2018 Factors influencing initial treatment effect and outcome of pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 478s Year: 2002 How much of a role does immunohistochemistry have in reaching a final diagnosis of pleural malignancy in routine clinical practice? Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012 Clinical, radiological, and bacteriological features of tuberculosis (TB) in teenagers' initial treatment and outcome Source: Eur Respir J 2005; 26: Suppl. 49, 648s Year: 2005 COPD detected with screening: impact on patient management and prognosis Source: Eur Respir J 2014; 44: 1571-1578 Year: 2014 Study of the relation of TNF-α and performance of tuberculosis patients and role of TNF-α as an additional laboratuary method in diagnosis Source: Eur Respir J 2003; 22: Suppl. 45, 342s Year: 2003 The impact of revealing the diagnosis of TB on emotional level Source: Annual Congress 2007 - Epidemiology of tuberculosis II Year: 2007 A single centre study of COVID-19 patients: correlation with DDIMER and outcomes Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021 Time related change of etiologi and outcome in two large cohorts of pleural infection. Source: International Congress 2017 – From microbiology to clinical work Year: 2017